SetPoint Medical makes the SetPoint System, an implanted vagus-nerve stimulator the FDA approved in July 2025 for adults with moderate-to-severe rheumatoid arthritis who do not respond to or cannot tolerate biologic drugs.
Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.
The Briefing, free: frontier tech in under 10 minutes, every morning, read or listened to. Yours to keep after the week.
30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Video
What's hyped on 1,200+ official company channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.